他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识

被引：58

作者：

机构：

[1] 他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识组

来源：

中国卒中杂志 | 2013年 / 07期

关键词：

他汀; 治疗; 卒中; 缺血性; 短暂性脑缺血发作;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

1002 ;

摘要：

卒中已成为中国人口死亡和致残的第一位原因,尽管脑血管病的诊疗技术不断提高,但缺血性卒中的病死率、复发率和致残率仍居高不下,危险因素的全面管理对减少复发和残疾至关重要。血脂异常是公认的缺血性卒中/短暂性脑缺血发作(transient ischemic attack,TIA)的可控危险因素之一,为了更好地指导神经科医师的临床实践,本刊组织我国部分神经科专家,在参考旧版《他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识》(以下简称共识)基础上[1],全面复习他汀相关最新文献,结合中国国情和临床现状,制定更新版《他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识》,并附以研究证据等级及推荐强度(表1[2]),以期指导神经科医师合理地使用他汀类药物,科学地防治缺血性卒中/TIA。

引用

页码：565 / 575

页数：11

共 54 条

[41]

Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial[J] . Pierre Amarenco,Larry B. Goldstein,Michael Szarek,Henrik Sillesen,Amy E. Rudolph,Alfred Callahan,Michael Hennerici,Lisa Simunovic,Justin A. Zivin,K Michael A. Welch.Stroke . 2007 (12)

[42]

Stroke in China: epidemiology, prevention, and management strategies[J] . Ming Liu,Bo Wu,Wen-Zhi Wang,Li-Ming Lee,Shi-Hong Zhang,Ling-Zhi Kong.Lancet Neurology . 2007 (5)

[43] Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients [J].

Wong, K. S. ;

Ng, P. W. ;

Tang, A. ;

Liu, R. ;

Yeung, V. ;

Tomlinson, B. .

NEUROLOGY, 2007, 68 (23) :2035-2038

[44]

Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis[J] . Matthias W. Lorenz,Hugh S. Markus,Michiel L. Bots,Maria Rosvall,Matthias Sitzer.Circulation . 2007 (4)

[45] Clinical perspectives of statin-induced rhabdomyolysis [J].

Antons, KA ;

Williams, CD ;

Baker, SK ;

Phillips, PS .

AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05) :400-409

[46]

Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis[J] . Pierre Amarenco,Julien Labreuche,Philippa Lavallée,Pierre-Jean Touboul.Stroke . 2004 (12)

[47]

Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study[J] . Shinya Okazaki,Takayuki Yokoyama,Katsumi Miyauchi,Kazunori Shimada,Takeshi Kurata,Hitoshi Sato,Hiroyuki Daida.Circulation . 2004 (9)

[48]

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial[J] . Helen M Colhoun,D John Betteridge,Paul N Durrington,Graham A Hitman,H Andrew W Neil,Shona J Livingstone,Margaret J Thomason,Michael I Mackness,Valentine Charlton-Menys,John H Fuller.The Lancet . 2004 (9435)

[49] Current overview of statin-induced myopathy [J].

Rosenson, RS .

AMERICAN JOURNAL OF MEDICINE, 2004, 116 (06) :408-416

[50]

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines[J] . Scott M. Grundy,James I. Cleeman,C. Noel Bairey Merz,H. Bryan Brewer,Luther T. Clark,Donald B. Hunninghake,Richard C. Pasternak,Sidney C. Smith,Neil J. Stone.Journal of the American College of Cardiology . 2004 (3)

← 1 2 3 4 5 6 →